#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cold type haemolytic anaemia Infantile apnoea Non-small cell lung cancer metastatic Congenital aplastic anaemia Systemic sclerosis pulmonary Hyperphagia Congenital generalised lipodystrophy Angiosarcoma non-metastatic Fallopian tube cancer Glioblastoma IgA nephropathy Hereditary spastic paraplegia Follicle centre lymphoma follicular grade I, II – III Metastatic malignant melanoma Ovarian cancer stage III More trials…

    Learn about Rare Diseases

    Ehlers-Danlos syndrome – Basic Information Haemolytic uraemic syndrome – Treatment Cerebral arteriovenous malformation haemorrhagic Anaplastic thyroid cancer – Treatment Haemophagocytic lymphohistiocytosis Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Idiopathic pulmonary fibrosis Bronchiolitis obliterans syndrome – Diagnostics Thrombotic thrombocytopenic purpura – Diagnostics Hereditary neuropathic amyloidosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Medi0618 Etifoxine Hydrochloride RP3 Felzartamab Bemnifosbuvir Hemisulfate Avalglucosidase Alfa Ziltivekimab Ly3454738 Keto-Leucine Calcium 68Ga-Nota-Abscint-Her2 2,4 DICHLOROBENZYL ALCOHOL Gen1053 Giroctocogene Fitelparvovec Acetylcysteine Amide Digitoxin Sodium Phenylbutyrate DUVELISIB Nemtabrutinib Aclidinium Bromide Trazodone More therapies…

    Learn about Your Condition

    Ebola disease Chronic hepatitis B Actinic cheilitis Gastric cancer recurrent Hyperlipidaemia Schizoaffective disorder Cardiac ventricular thrombosis Follicular thyroid cancer External cephalic version Haemofiltration Oral lichen planus Post procedural hypotension Pneumonia chlamydial Porphyria non-acute Dementia with Lewy bodies More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Post-Surgery Treatment for Colon Cancer Patients Using Trifluridine, Irinotecan, and Drug Combination

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colon cancer stage II
    • Colon cancer stage III
    Investigated Drugs:
    • Irinotecan
    • Oxaliplatin
    • Trastuzumab
    Italy

  • Study on Trabectedin and Radiotherapy for Patients with Soft Tissue Sarcoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Trabectedin
    France Italy Spain

  • Study on Time-Restricted Eating and Metformin for Patients with Invasive Breast Cancer or Ductal Carcinoma In Situ

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Metformin Hydrochloride
    Italy

  • Study on the Effects of Moxifloxacin and Drug Combination for Patients with Acute Appendicitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Ertapenem
    • Moxifloxacin
    • Levofloxacin
    Finland

  • Study on the Effects of Ubiquinol and Ascorbic Acid for Patients with Mitochondrial Disorders and Cerebellar Ataxias

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cerebellar ataxia
    Investigated Drugs:
    • Ubiquinol
    • Ascorbic Acid
    Spain

  • Study Comparing Different Antibiotic Treatments for ICU Patients with Hospital-Acquired Sepsis: Focus on Cefepime and Drug Combination

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Sepsis
    Investigated Drugs:
    • Amikacin
    • Avibactam
    • Ceftazidime
    France
Previous Page
1 … 832 833 834 835 836 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!